PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area.
Antoine VergerAurélie KasJacques DarcourtEric GuedjPublished in: Cancers (2022)
PET plays an increasingly important role in the management of brain tumors. This review outlines currently available PET radiotracers and their respective indications. It specifically focuses on 18 F-FDG, amino acid and somatostatin receptor radiotracers, for imaging gliomas, meningiomas, primary central nervous system lymphomas as well as brain metastases. Recent advances in radiopharmaceuticals, image analyses and translational applications to therapy are also discussed. The objective of this review is to provide a comprehensive overview of PET imaging's potential in neuro-oncology as an adjunct to brain MRI for all medical professionals implicated in brain tumor diagnosis and care.
Keyphrases
- pet imaging
- palliative care
- brain metastases
- positron emission tomography
- healthcare
- small cell lung cancer
- amino acid
- computed tomography
- magnetic resonance imaging
- high resolution
- high grade
- contrast enhanced
- deep learning
- quality improvement
- machine learning
- magnetic resonance
- multiple sclerosis
- mesenchymal stem cells
- affordable care act
- binding protein
- bone marrow
- pain management
- photodynamic therapy
- climate change